Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Martin Marietta Materials, Inc., a leading supplier of aggregates and building materials, appointed Chris Samborski as Executive Vice President and Chief Operating Officer effective May 1, 2026. Samborski brings extensive leadership experience from his previous roles within Martin Marietta and other major corporations such as Caterpillar and Johnso…
Verizon Communications Inc. reported solid financial and operating results for the first quarter of 2026, showcasing accelerating momentum in its strategic transformation efforts. The company achieved its highest quarterly adjusted EBITDA in history, positive postpaid phone net additions for the first time in over a decade, and raised its 2026 adju…
Oruka Therapeutics announced positive interim data from its EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe plaque psoriasis patients. The treatment achieved a 63.5% complete skin clearance rate (PASI 100) at 16 weeks with a safety profile similar to placebo and existing IL-23p19 inhibitors. Updated pharmacokinetic data support potentia…
Astec Industries, a manufacturer of specialized equipment for asphalt road building, aggregate processing, and concrete production, announced a quarterly dividend of $0.13 per share payable on May 29, 2026, to shareholders of record on May 13, 2026. The company operates in two main segments: Infrastructure Solutions and Materials Solutions, and als…
Sionna Therapeutics has completed enrollment in its PreciSION CF Phase 2a proof-of-concept trial, which evaluates its first-in-class NBD1 stabilizer, SION-719, added to the current cystic fibrosis standard of care Trikafta. Data from the trial is expected in summer 2026. This marks the first clinical study targeting the nucleotide binding domain 1 …
Fulcrum Therapeutics announced positive clinical data from its Phase 1b PIONEER trial of pociredir for sickle cell disease, showing significant fetal hemoglobin induction and improvements in markers of hemolysis, anemia, and potential reduction in vaso-occlusive crises. The company plans to initiate a registration-enabling trial in the second half …
Lakeland Financial Corporation announced record first quarter 2026 net income of $26.5 million, a 32% increase from the prior year quarter, driven by 5% loan growth, strong net interest margin expansion, and 18% higher noninterest income. The bank experienced healthy organic loan growth, improved asset quality, and increased shareholder returns via…
Aeluma, a NASDAQ-listed semiconductor company, has appointed Dr. Willy Rachmady as Vice President of Strategic Partnerships and Ecosystem. With over 20 years at Intel and extensive expertise in advanced semiconductor technologies, Dr. Rachmady will focus on building strategic manufacturing partnerships and accelerating commercialization of Aeluma's…
Barclays, in its European Tactical Playbook, spots a trio of media-related companies it classifies as 'oversold quality' where current market sentiment and valuation appear disconnected from underlying prospects. Canal+, CTS Eventim and Informa are presented as tactical opportunities with asymmetric upside driven by international growth, potential …
Pope Leo and Sarah Mullally, the newly installed Archbishop of Canterbury and the first woman to lead the Anglican Communion, met at the Vatican on April 27 for their first formal encounter. The leaders exchanged gifts, prayed together in a 17th century chapel, and spoke of progress in relations between the Roman Catholic Church and the Church of E…
Bank of America analysts recommend hedging exposure to the British pound despite a strong April for the currency, citing a historically weak May seasonal pattern, low market-implied volatility, and what they see as underpriced political uncertainty ahead of local elections. Technical indicators on GBP/USD add to the downside case, and the bank iden…
SCHMID Group N.V. announced preliminary Q1 2026 results with order intake of €13.6 million and revenues of €18.2 million, noting Q1 is traditionally soft. The company reaffirmed its full-year 2026 guidance expecting revenues over €100 million, an Adjusted EBITDA margin above 12%, and order intake around €114 million. Significant financial maneuvers…
Yardeni Research contends that the market low reached on March 30 represents the floor for U.S. equities this year and restates a year-end S&P 500 objective of 7,700. The firm draws a parallel to the 1956 Suez Crisis, notes continued disruptions around the Strait of Hormuz and highlights a resilient earnings backdrop and improving credit flows as r…
Fulcrum Therapeutics appointed Dr. Josh Lehrer, a seasoned physician-scientist with extensive drug development experience in rare diseases, to its Board of Directors. Dr. Lehrer’s background includes leadership roles in developing therapies for sickle cell disease, notably contributing to the approval of Oxbryta. His addition is expected to bolster…
In a turbulent month for markets marked by earnings, geopolitical uncertainty tied to the US/Iran ceasefire, and a re-evaluation of long-term interest rates, an AI-driven selection process delivered exceptional short-term returns. Subscribers to the InvestingPro AI stock lists received April recommendations that produced ten winners up more than 30…
Seaport Therapeutics, a clinical-stage biotechnology company based in Boston, has filed for a U.S. initial public offering that would value the company at $912 million. The firm is proposing to sell 11.8 million shares at $16 to $18 each to raise up to $212.4 million, and plans to list on the Nasdaq Global Market under the symbol SPTX. The filing c…
Eton Pharmaceuticals has begun dosing patients in a clinical pilot study for ET-700, an extended-release zinc acetate formulation targeting treatment of Wilson disease. The study aims to evaluate ET-700's efficacy in reducing intestinal copper absorption with a simpler dosing regimen. Positive results expected in late 2026 could lead to a pivotal t…
Invesco's Asia Pacific head of fixed income portfolio management views the three- to seven-year segment of India's government bond curve as attractive, arguing that recent sell-offs and rate-hike concerns driven by geopolitical tensions and higher crude prices could be excessive. The firm highlights the importance of inflation pass-through, crude o…
The United States has moved to relax a sanctions restriction that had stopped Venezuela’s government from paying legal fees for Nicolás Maduro and his wife Cilia Flores, according to a court filing. The change removes a hurdle that had prompted defense counsel to ask a Manhattan judge to dismiss the narcotics-related prosecution on the grounds that…
Oilfield service companies have begun removing drilling rigs and specialized equipment held in storage in Venezuela and preparing them for repair and deployment as a government-led review of oil and gas contracts advances. The review - set to conclude by the end of July after a major oil law reform in January - has prompted initial agreements and p…
JPMorgan's equity strategy team, led by Mislav Matejka, is urging investors to treat market weakness tied to the Middle East conflict as a buying opportunity rather than a trigger to turn defensive. The bank highlights constraints on a prolonged military confrontation, a milder wages and inflation backdrop than in 2022, policy rates near historical…
Global markets begin the week with rising oil prices amid a stalemate in Iran and constrained Strait of Hormuz traffic, while technology shares - led by chipmakers and an extraordinary rally in Intel - continue to climb as major tech firms prepare to report earnings. Central bank meetings and U.S. inflation data are scheduled this week, with invest…
An Egyptian family living in Colorado who were ordered released from more than 10 months of immigration detention were briefly taken back into federal custody less than 48 hours after a judge's release order. Authorities detained the mother and her five children during a mandated check-in at an ICE office in Denver and moved them toward a planned f…
Citi Research says European oilfield services stocks remain attractively valued despite a 47% year-to-date surge, citing below-historical multiples and a persistent discount versus U.S. peers. The bank highlights Saipem, Subsea 7 and Technip Energies as leading names in the subsector and projects stronger EBITDA growth for European services firms t…
Leonardo appears to be addressing its biggest structural weakness - poor cash conversion and a bloated working capital profile - through tighter contract execution, divestments and sharper inventory control. That operational pivot, combined with steady European defense spending, supports a tactical long with defined entry, stop and target levels ov…
